* Glaukos Corp GKOS.N reported a quarterly adjusted loss
of 28
cents per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -50 cents. The mean expectation of twelve analysts for the
quarter was for a loss of 48 cents per share. Wall Street
expected results to range from -54 cents to -31 cents per share.
* Revenue rose 23.9% to $96.67 million from a year ago;
analysts
expected $91.49 million.
* Glaukos Corp's reported EPS for the quarter was a loss
of 39
cents.
* The company reported a quarterly loss of $21.41 million.
* Glaukos Corp shares had risen by 0.8% this quarter and
gained 65.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Glaukos Corp is
145.00
This summary was machine generated from LSEG data November 5 at
07:44 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.48 -0.28 Beat
Jun. 30 2024 -0.51 -0.52 Missed
Mar. 31 2024 -0.57 -0.70 Missed
Dec. 31 2023 -0.55 -0.63 Missed